Kenneth T. Mills - Net Worth and Insider Trading

Kenneth T. Mills Net Worth

The estimated net worth of Kenneth T. Mills is at least $6 Million dollars as of 2024-04-20. Kenneth T. Mills is the President and CEO of Regenxbio Inc and owns about 408,035 shares of Regenxbio Inc (RGNX) stock worth over $6 Million. Details can be seen in Kenneth T. Mills's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth T. Mills has not made any transactions after 2024-04-15 and currently still holds the listed stock(s).

Transaction Summary of Kenneth T. Mills

To

Kenneth T. Mills Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth T. Mills owns 1 companies in total, including Regenxbio Inc (RGNX) .

Click here to see the complete history of Kenneth T. Mills’s form 4 insider trades.

Insider Ownership Summary of Kenneth T. Mills

Ticker Comapny Transaction Date Type of Owner
RGNX Regenxbio Inc 2024-04-15 director & See Remarks

Kenneth T. Mills Latest Holdings Summary

Kenneth T. Mills currently owns a total of 1 stock. Kenneth T. Mills owns 408,035 shares of Regenxbio Inc (RGNX) as of April 15, 2024, with a value of $6 Million.

Latest Holdings of Kenneth T. Mills

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RGNX Regenxbio Inc 2024-04-15 408,035 15.69 6,402,069

Holding Weightings of Kenneth T. Mills


Kenneth T. Mills Form 4 Trading Tracker

According to the SEC Form 4 filings, Kenneth T. Mills has made a total of 22 transactions in Regenxbio Inc (RGNX) over the past 5 years, including 0 buys and 22 sells. The most-recent trade in Regenxbio Inc is the sale of 15,000 shares on April 15, 2024, which brought Kenneth T. Mills around $272,850.

Insider Trading History of Kenneth T. Mills

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kenneth T. Mills Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kenneth T. Mills Ownership Network

Ownership Network List of Kenneth T. Mills

No Data

Ownership Network Relation of Kenneth T. Mills


Kenneth T. Mills Owned Company Details

What does Regenxbio Inc do?

Who are the key executives at Regenxbio Inc?

Kenneth T. Mills is the director & See Remarks of Regenxbio Inc. Other key executives at Regenxbio Inc include Chief Medical Officer Steve Pakola , See Remarks Vittal Vasista , and director & 10 percent owner Allan M. Fox .

Regenxbio Inc (RGNX) Insider Trades Summary

Over the past 18 months, Kenneth T. Mills made 5 insider transaction in Regenxbio Inc (RGNX) with a net sale of 135,000. Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 12,878 shares made by Steve Pakola ,

In summary, during the past 3 months, insiders sold 57,878 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 57,878 shares. During the past 18 months, 147,878 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 147,878 shares.

Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regenxbio Inc Insider Transactions

No Available Data

Kenneth T. Mills Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth T. Mills. You might contact Kenneth T. Mills via mailing address: C/o Regenxbio Inc., 9804 Medical Center Drive, Rockville Md 20850.

Discussions on Kenneth T. Mills

No discussions yet.